SCHEMBL926008

SCHEMBL926008

NC(=O)C(Oc1ccccc1)OC(F)C(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 2/20 0.36
POLB P06746 1/20 0.35
CTNNB1 P35222 1/20 0.34
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34
GRM2 Q14416 1/20 0.34
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
PPARG P37231 3/20 0.33
PPARA Q07869 3/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP1A2 P05177 1/20 0.33
GAA P10253 1/20 0.33
CYP2C9 P11712 1/20 0.33
PKM P14618 1/20 0.33
CYP2C19 P33261 1/20 0.33
MAPT P10636 1/20 0.33
TEAD4 Q15561 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALOX5 P09917 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11884465 0.82 PARP10 (0.45) PARP10POLBCTNNB1MTNR1AMTNR1B
SCHEMBL7669989 0.75 POLB (0.42) PARP10POLBCTNNB1MTNR1AMTNR1B
SCHEMBL5251553 0.75 EPHX1 (0.39) PARP10POLBCTNNB1MTNR1AMTNR1B
SCHEMBL28319983 0.74 PARP10 (0.42) PARP10POLBCTNNB1MTNR1AMTNR1B
SCHEMBL926005 0.74 MAPK1 (0.41) PARP10POLBMTNR1AMTNR1BMEN1
SCHEMBL28382395 0.72 PARP10 (0.38) PARP10POLBCTNNB1MTNR1AMTNR1B
SCHEMBL9116662 0.72 MTNR1A (0.42) PARP10POLBMTNR1AMTNR1BPPARG
SCHEMBL2970016 0.71 LTA4H (0.41) MTNR1AMTNR1BMEN1KMT2APPARG
SCHEMBL31560867 0.71 CYP1A2 (0.47) PPARGPPARACYP1A2GAACYP2C9
SCHEMBL10436877 0.70 TAAR1 (0.44) PARP10POLBMTNR1AMTNR1BPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110021473-A1 INHIBITORS OF PHOSPHODIESTERASE TYPE-IV RANBAXY LABORATORIES LIMITED 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021473-A1 INHIBITORS OF PHOSPHODIESTERASE TYPE-IV PDE4A, PDE4B, PDE4C PARP10 1944/4885POLB 1077/4885CTNNB1 3326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.